Use of 2-(2-Nitro-4-Trifluoromethylbenzoyl)-l,3Cyclohexanedione in the treatment of Parkinson's disease

Details for Australian Patent Application No. 2006217650 (hide)

International Classifications

Event Publications

13 September 2007 PCT application entered the National Phase

PCT publication WO2006/090177 Priority application(s): WO2006/090177

9 June 2011 Application Accepted

Published as AU-B-2006217650

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.